Cite
MLA Citation
D Varghese et al.. “P632 Vedolizumab dose escalation in patients with inflammatory bowel disease experiencing loss of response: A systematic review and meta-analysis of real-world evidence.” Journal of Crohn's and colitis, vol. 14, n.d., pp. S524–S525. http://access.bl.uk/ark:/81055/vdc_100099171740.0x00003d